Join the Spinal Spasticity group to help and get support from people like you.
Spinal Spasticity News (Page 2)
Generic Medications Can Keep OOP Costs Down for Neurological Conditions
WEDNESDAY, Oct. 30, 2024 – Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, for which costs continue to increase, according...
FDA Approves Injectable Ocrevus Zunovo for Relapsing, Progressive MS
THURSDAY, Sept. 26, 2024 – The U.S. Food and Drug Administration has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) as the first and only twice-a-year, 10-minute subcutaneous injection...
Could Having MS Help Shield Against Alzheimer's Disease?
TUESDAY, Aug. 27, 2024 – People with multiple sclerosis appear to have a lower risk of developing Alzheimer’s disease, a new study suggests. MS patients are far less likely to have elevated blood l...
Most Patients With MS Have No Risk for Relapse After COVID-19 Vaccination
WEDNESDAY, Aug. 14, 2024 – For most patients with multiple sclerosis (MS), there is no increased risk for relapse after COVID-19 vaccination, according to a study published online Aug. 14 in...
Most Patients With MS Have No Risk for Relapse After COVID-19 Vaccination
WEDNESDAY, Aug. 14, 2024 – For most patients with multiple sclerosis (MS), there is no increased risk for relapse after COVID-19 vaccination, according to a study published online Aug. 14 in...
Ipsen Biopharmaceuticals, Inc. Announces FDA Approval of Dysport (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Pediatric Patients Aged Two and Older
BASKING RIDGE, N.J., Aug. 1, 2016 /PRNewswire/ – Ipsen Biopharmaceuticals, Inc., a subsidiary of Ipsen SA (Euronext: IPN; ADR: IPSEY) (Ipsen), today announced that the U.S. Food and Drug...